Company news: LGP/Reset; Melodiol; AusCann; Elixinol by Martin Lane February 21, 2024February 21, 2024 Psychedelics firm Reset Mind Sciences will remain a subsidiary of Little Green Pharma after dropping plans […]
Clarity over German legal scheme paves way for AusCann-Eurocann deal by Steve Jones February 7, 2024February 7, 2024
Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024February 1, 2024
Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare by Martin Lane December 4, 2023December 8, 2023
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne by Martin Lane and Steve Jones September 4, 2023September 4, 2023
AusCann set to import product from Germany under Eurocann tie-up by Steve Jones July 26, 2023July 26, 2023
Former AusCann CEO joins MGC Pharma as non-executive director by Steve Jones June 5, 2023June 5, 2023